An Observational Study of the Digital Platform Use for the Preparation and Monitoring of Patients With Scheduled Outpatient Colonoscopy

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this clinical trial investigation with device is to to analyze the use of the Caaring® digital platform for the preparation and follow-up of scheduled colonoscopy. Colonoscopy is a difficult procedure, and it is estimated that bowel preparation is inadequate in about 25% of patients. The main question it aims to answer is if the use of a digital platform (Caaring®) could be an effective tool for reducing the percentage of inadequate bowel preparations in patients with a scheduled colonoscopy. To this end, the application will provide precise instructions to patients. A prospective, single-center, observational study with software device: The recruitment phase is expected to last two months. Patients will be followed for one month after the colonoscopy and 14 days prior to it. Additionally, measuring patient experience and monitoring adverse effects after a colonoscopy are crucial to improving the safety of colonoscopies and the quality of healthcare, promoting higher quality colonoscopy services. For that to happen, participants must have sufficient technological skills to use a smartphone.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age 18 or older.

• Signed informed consent.

• Patients scheduled for outpatient colonoscopy.

• Patients able to complete the study questionnaires.

• Patients who regularly use a smartphone

Locations
Other Locations
Spain
Hospital Clínic de Barcelona
RECRUITING
Barcelona
Contact Information
Primary
Roberto Bravo
roberto.bravo@perseivivarium.com
+34 915004013
Time Frame
Start Date: 2025-03-13
Estimated Completion Date: 2025-08
Participants
Target number of participants: 225
Related Therapeutic Areas
Sponsors
Leads: Persei Vivarium
Collaborators: Effice Servicios Para la Investigacion S.L.

This content was sourced from clinicaltrials.gov